Factbox-Foreign companies eye US expansion to lessen fallout from tariffs

Core Insights - Non-U.S. companies are planning to expand or establish operations in the United States to counteract the effects of President Trump's tariffs on imported goods Company Investments - Air Liquide plans to invest up to $200 million in Louisiana and over $50 million in the U.S. semiconductor industry [2] - AstraZeneca intends to spend $50 billion on a new plant in Virginia and expansions in several states including Maryland, Massachusetts, California, Indiana, and Texas [3] - Honda aims to shift some car production from Mexico and Canada to the U.S., targeting 90% local production for cars sold in the country [4] - Hyundai Motor is localizing production in the U.S. and will manufacture hybrid vehicles at a new factory in Georgia [5] - Inventec has agreed to invest up to $85 million to build manufacturing facilities in Texas [6] - Lavazza plans to increase its U.S. production from 50% to 100% of its sales [7] - Nissan is considering moving production of its Sentra automobile from Mexico to the U.S. and shifting some domestic production of U.S.-bound vehicles [8] - Novartis plans to invest $23 billion to build and expand 10 facilities in the U.S. [9] - Roche will invest $50 billion in the U.S. over the next five years and announced an additional $550 million for its Indianapolis diagnostics manufacturing hub [10] - Rolls-Royce plans a $75 million investment to enhance U.S. manufacturing capabilities in South Carolina [11] - Samsung Electronics is considering relocating dryer manufacturing from Mexico to its South Carolina plant [13] - Sanofi plans to invest at least $20 billion in the U.S. through 2030 to enhance manufacturing and research [14] - Stellantis is set to invest about $10 billion in the United States [15]